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C BY-NC-Abstract In the present study we have designed a new pharmacophore ‘Chalconesemicarbazone’
by pharmacophore hybridization approach of drug design. A series of novel chalconesemicarbaz-
ones was synthesized and evaluated for their antioxidant activity by reducing power assay. Most
of the compounds were found to be potent antioxidants. Free radicals play an important role in
various pathological and xenotoxic effects so antioxidant may have protective role in these patho-
logical conditions. Based on the results of reducing power assay 1-[1-(2,4-dihydroxyphenyl)-3-(2-
hydroxyphenyl)allylidene]-4-(4-methylphenyl)semicarbazide (compound 18) and 1-[1-(2,5-dihy-
droxyphenyl)-3-(6-hydroxyphenyl)allylidene]-4-(4-methylphenyl)semicarbazide (compound 21)
were the most active lead compounds. It was found that methoxy and hydroxyl substituted chalco-
nesemicarbazones exhibited potent reducing power and unsubstituted compound showed less
reducing potential.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.Open access under CC BY-NC-ND license.1. Introduction
Free radical is an atom or molecule that bears an unpaired
electron and is extremely reactive, capable of engaging in rapid29153193.
il.com (M. Singhal).
y. Production and hosting by
Saud University.
lsevier
ND license.change reaction that destabilize other molecules and generate
many more free radicals. In plants and animals these free rad-
icals are deactivated by antioxidants. These antioxidants act as
an inhibitor of the process of oxidation, even at relatively small
concentration and thus have diverse physiological role in the
body. The body is constantly exposed to the negative and
sometimes lethal effects of oxidants during normal physiolog-
ical processes. The harmful free radicals such as hydroxyl,
peroxyl and the superoxide anion are constantly being pro-
duced as a result of metabolic reactions in living systems. On
a daily basis, up to 5% of inhaled oxygen may be converted
to reactive oxygen species (ROS). These ROS have the ability
to bind to cellular structures, and have been implicated in a
number of pathological processes such as aging, inﬂammation,
re-oxygenation of ischemic tissues, atherosclerosis, cancer and
even Parkinson’s disease in men (Setiadi et al., 2003). Two
Figure 1 Pharmacophoreof thedesignedchalconesemicarbaz-one.
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Figure 2 In Silico metabolism of the chalconesemicarbazone.
122 M. Singhal et al.processes, which produce free radicals in vivo, have been iden-
tiﬁed and named the Fenton reaction and the Haber–Weiss
reaction.
Antioxidants play an important role in animal health.
Conventional antioxidants have been shown to improve animal
performance during conditions characterized by increased tissue
oxidant levels such as stress, injury and infections (Nickels,
2003). The semicarbazone is an electron withdrawing
group and exhibited antioxidant activity. Favorable substitu-
tion may increase their free radical scavenging effect (Dutta
et al., 2005).
In the present study we have used pharmacophore hybrid-
ization technique of drug design and designed a pharmaco-
phore model ‘chalconesemicarbazone’, which is having
hydrogen acceptor site, hydrogen donor site, lipophilic site
etc. (Fig. 1), which may help in binding with receptors and
plays an important role in pharmacological activities. On these
observations, we have designed a synthetic scheme to synthe-
size this pharmacophore, and also synthesize some leadcompounds. We have also done the pharmacological screening
as antioxidant activity by reducing power assay. No exact
mechanism study were done on molecular level but further
studies were in process in our lab for searching the exact mech-
anism of action of these compounds, which may support the
showing activities of the synthesized compounds.
In-Silico metabolism prediction of the synthesized com-
pounds is given in Fig. 2. The major pathway of metabolism
was found to be p-hydroxylation and amide hydrolysis how-
ever in some compounds glucuronide and sulfate conjugation
may also occur.2. Materials and methods
2.1. Chemistry
Chalconesemicarbazones were synthesized according to syn-
thetic scheme as shown in Fig. 3. Melting points were mea-
sured in open capillary tubes on a Buchi 530 melting point
apparatus and were uncorrected. Infrared (IR) and proton nu-
clear magnetic resonance (1H NMR) spectra were recorded for
the compounds on Jasco IR Report 100 (KBr) and Brucker
Advance (300 MHz) instruments, respectively. Chemical shifts
are reported in parts per million (ppm) using tetramethylsilane
(TMS) as an internal standard. All exchangeable protons were
conﬁrmed by addition of D2O. Mass spectra were measured
with a Shimadzu GC–MS–QP5000 spectrophotometer. Only
molecular ions (M+) and base peaks are given. Elemental
analysis (C, H and N) were undertaken with a Perkin-Elmer
model 240C analyzer, and all analyses were consistent with
theoretical values (within 0.4%) unless indicated. The homoge-
neity of the compounds was monitored by ascending thin-layer
chromatography (TLC) on silica gel G (Merck) coated alumi-
num plates, visualized by iodine vapor.
2.1.1. Synthesis of substituted chalcone derivatives
Substituted benzaldehydes (0.012 mol) were added to a mix-
ture of substituted acetophenones (0.01 mol) in 25 ml of etha-
nol in a 200 ml beaker. The content of the beaker was mixed
well and to that 10 ml of 10% potassium hydroxide solution
was added and stirred vigorously at 25 C until the mixture
was so thick that stirring was no longer effective (3–4 h).
After the completion of the stirring, the reaction mixture
was kept in a refrigerator overnight. The reaction mixture
was then diluted with ice-cold water (50 ml), acidiﬁed with
10% aqueous hydrochloric acid to precipitate the chalcones.
The product was ﬁltered with suction on a Buchner funnel,
washed with cold water until the washings were neutral to lit-
mus and then washed with 10 ml of ice-cold rectiﬁed spirit. The
dried product was recrystallized from chloroform. The physi-
cochemical properties of the synthesized chalcone derivatives
are given in Table 1.
2.1.2. Synthesis of methyl phenyl urea (2)
Substituted aniline (0.1 mol) was dissolved in 20 ml of glacial
acetic acid and 10 ml of water. To this, 0.1 mol of sodium cya-
nate (6.5 g) in 80 ml of warm water was added with continuous
stirring. The reaction mixture was allowed to stand for 30 min
and then cooled in ice. The crude solid, thus obtained was ﬁl-
tered, dried and recrystallized with boiling water to yield
methyl phenyl urea.
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Figure 3 Synthetic scheme for synthesizing the Chalconesemicarbazone compounds.
Table 1 Physicochemical properties of chalcone derivatives.
Comp. no. R1 R2 Molecular formula Mp (C) Yield (%) Rf value
1a H H C15H12O2 89 85 0.80
1b H 400-OH C15H12O3 164 85 0.83
1c H 400-OCH3 C16H14O3 135 85 0.82
1d H 400-N(CH3)2 C17H17NO2 155 85 0.78
1e 40-OH 600-OH C15H12O4 216 90 0.85
1f 40-OH 400-N(CH3)2 C17H17NO3 174 90 0.81
1g H 600-OH C15H12O3 166 85 0.86
1h 50OH 600-OH C15H12O4 218 85 0.84
1i 50OH 400-OH C15H12O4 208 85 0.87
1j 50OH 400-OCH3 C16H14O4 152 85 0.79
Synthesis and reducing power assay of methyl semicarbazone derivatives 1232.1.3. Synthesis of substituted phenyl semicarbazide (3)
Equimolar quantities (0.05 mol) of above phenyl urea (2) and
hydrazine hydrate (2.5 ml) in ethanol were reﬂuxed for 27 h
with continuous stirring. The two-third volume of ethanol
was distilled by vacuum distillation unit and then poured into
ice. The resultant crude solid was ﬁltered, washed with water
and dried. The obtained solid was recrystallized with 50 ml
of 90% alcohol.
2.1.4. General method for the synthesis of substituted phenyl
chalconesemicarbazone
To a solution of above (3) (0.005 mol) in 25 ml of ethanol
added an equimolar quantity of the appropriate chalcone
derivative previously dissolved in ethanol. Then few drops of
Con. hydrochloric acid was added and continuously stirred
for 4–5 h.
The reaction mixture was poured into ice and precipitate,
so obtained was ﬁltered, washed with sodium acetate
(0.005 mol, 0.41 g) in 2 ml water. The crude solid was driedand recrystallized with hot ethanol. The structures (Fig. 4)
and physicochemical properties of the synthesized title com-
pounds are given in Table 2.
2.1.4.1. 1-[1-(2-Hydroxyphenyl)-3-phenylallylidene]-4-(2-
methylphenyl)semicarbazide (4). 1H NMR (d/ppm in CDCl3):
2.12 (s, 3H, Ar–CH3), 4.83 (s, 1H, 2-OH), 7.11–7.64 (m,
J= 8.32 Hz, 12H, Ar–H) 7.7 (s, 1H, –CH‚CH–), 7.9 (s,
1H, –CH‚CH–), 8.34 (s, 1H, ArNH, D2O exchangeable),
9.42 (s, 1H, CONH, D2O exchangeable); IR (KBr/cm
1):
3450 (NH), 3480 (–OH), 3300–3240 (CONH), 1670
(–CH‚CH–), 1590 (C–N), 1616, 1558 (aromatic), 754, 697
(monosubstituted benzene); MS, m/z 370; Elemental analysis
calculated/found (%) C (74.37/74.26), H (5.70/5.48), N
(11.31/11.12).
2.1.4.2. 1-[1-(2-Hydroxyphenyl)-3-(4-hydroxyphenyl)allylid-
ene]-4-(2-methylphenyl)semicarbazide (5). 1H NMR (d/ppm
in CDCl3): 2.18 (s, 3H, Ar–CH3), 4.9 (s, 1H, 2-OH), 5.2 (s,
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Figure 4 Structure of synthesized title compounds.
124 M. Singhal et al.1H, 4-OH), 7.3–7.64 (m, J= 8.4 Hz, 11H, Ar–H) 7.8 (s, 1H,
–CH‚CH–), 8.0 (s, 1H, –CH‚CH–), 8.44 (s, 1H, ArNH,
D2O exchangeable), 9.8 (s, 1H, CONH, D2O exchangeable);
IR (KBr/cm1): 3455 (NH), 3475 (–OH), 3310–3245 (CONH),
1675 (–CH‚CH–), 1594 (C–N), 1615, 1556 (aromatic), 750,
695 (monosubstituted benzene); MS, m/z 386; Elemental anal-
ysis, cal/fou (%) C (71.30/71.24), H (5.46/5.35), N (10.85/
10.47).
2.1.4.3. 1-[1-(2-Hydroxyphenyl)-3-(4-methoxyphenyl)allylid-
ene]-4-(2-methylphenyl)semicarbazide (6). 1H NMR (d/ppm
in CDCl3): 2.16 (s, 3H, Ar–CH3), 4.7 (s, 1H, 2-OH), 3.88 (s,
3H, 4-OCH3), 7.12–7.85 (m, J= 8.3 Hz, 11H, Ar–H), 7.98
(s, 1H, –CH‚CH–), 8.35 (s, 1H, –CH‚CH–), 8.87 (s, 1H,
ArNH, D2O exchangeable), 9.86 (s, 1H, CONH, D2O
exchangeable); IR (KBr/cm1): 3458 (NH), 3478 (–OH),
3310–3243 (CONH), 1677 (–CH‚CH–), 1587 (C–N), 1626,
1555 (aromatic), 758, 687 (monosubstituted benzene); MS,
m/z 400; Elemental analysis cal/fou (%) C (71.80/71.57), H
(5.77/5.48), N (10.47/10.36).Table 2 Physicochemical data of methyl semicarbazones.
Comp. no. R R1 R2 Yield (%
4 2-CH3 H H 57
5 2-CH3 H 4
00-OH 66
6 2-CH3 H 4
00-OCH3 65
7 2-CH3 H 4
00-N(CH3)2 58
8 2-CH3 4-OH 6
00-OH 57
9 2-CH3 4-OH 4
00-N(CH3)2 50
10 2-CH3 H 6
00-OH 63
11 2-CH3 5-OH 6
00-OH 61
12 2-CH3 5-OH 4
00-OH 56
13 2-CH3 5-OH 4
00-OCH3 57
14 4-CH3 H H 52
15 4-CH3 H 4
00-OH 65
16 4-CH3 H 4
00-OCH3 63
17 4-CH3 H 4
00-N(CH3)2 64
18 4-CH3 4-OH 6
00-OH 55
19 4-CH3 4-OH 4
00-N(CH3)2 56
20 4-CH3 H 6
00-OH 54
21 4-CH3 5-OH 6
00-OH 67
22 4-CH3 5-OH 4
00-OH 50
23 4-CH3 5-OH 4
00-OCH3 562.1.4.4. 1-[1-(2,4-Dihydroxyphenyl)-3-(2-hydroxyphenyl)ally-
lidene]-4-(2-methylphenyl)semicarbazide (9). 1HNMR (d/ppm
in CDCl3): 2.48 (s, 3H, Ar–CH3), 5.1 (s, 1H, 2-OH), 5.3 (s, 1H,
4-OH), 6.4 (s, 1H, 6-OH), 7.22–7.58 (m, J= 8.5 Hz, 10H,
Ar–H) 7.88 (s, 1H, –CH‚CH–), 8.4 (s, 1H, –CH‚CH–), 8.77
(s, 1H, ArNH, D2O exchangeable), 9.85 (s, 1H, CONH, D2O
exchangeable); IR (KBr/cm1): 3453 (NH), 3482 (–OH),
3314–3242 (CONH), 1667 (–CH‚CH–), 1594 (C–N), 1618,
1552 (aromatic), 758, 687 (monosubstituted benzene); MS, m/z
402; Elemental analysis cal/fou (%) C (68.47/68.44), H (5.25/
5.16), N (10.42/10.37).
2.1.4.5. 1-[1-(2-Hydroxyphenyl)-3-(2-hydroxyphenyl)allylid-
ene]-4-(2-methylphenyl)semicarbazide (11). 1H NMR (d/ppm
in CDCl3): 2.24 (s, 3H, Ar–CH3), 5.1 (s, 1H, 2-OH), 5.3 (s, 1H,
2, 4-OH), 7.2–7.78 (m, J= 8.35 Hz, 11H, Ar–H), 7.8 (s, 1H,
–CH‚CH–), 8.2 (s, 1H, –CH‚CH–), 8.78 (s, 1H, ArNH,
D2O exchangeable), 9.84 (s, 1H, CONH, D2O exchangeable);
IR (KBr/cm1): 3462 (NH), 3488 (–OH), 3300–3240 (CONH),
1666 (–CH‚CH–), 1593 (C–N), 1618, 1554 (aromatic), 753,
694 (monosubstituted benzene); MS, m/z 386; Elemental anal-
ysis cal/fou (%) C (71.30/71.17), H (5.46/5.37), N (10.85/
10.66).
2.1.4.6. 1-[1-(2,5-Dihydroxyphenyl)-3-(4-hydroxyphenyl)ally-
lidene]-4-(2-methylphenyl)semicarbazide (13). 1H NMR (d/
ppm in CDCl3): 2.16 (s, 3H, Ar–CH3), 5.4 (s, 1H, 2-OH) 5.2 (s,
1H, 4-OH), 5.6 (s, 3H, 5-OH) 7.22–7.88 (m, J= 8.6 Hz, 10H,
Ar–H), 7.84 (s, 1H, –CH‚CH–), 8.4 (s, 1H, –CH‚CH–),
8.82 (s, 1H, ArNH, D2O exchangeable), 9.96 (s, 1H, CONH,
D2O exchangeable); IR (KBr/cm
1): 3456 (NH), 3482 (–OH),
3310–3245 (CONH), 1667 (–CH‚CH–), 1593 (C–N), 1615,
1552 (aromatic), 755, 693 (monosubstituted benzene); MS, m/z
402; Elemental analysis cal/fou (%) C (68.47/68.28), H (5.25/
5.17), N (10.42/10.08).
2.1.4.7. 1-[1-(2-Hydroxyphenyl)-3-phenylallylidene]-4-(4-meth-
ylphenyl)semicarbazide (14). 1H NMR (d/ppm in CDCl3): 2.15) Mol Wt. Mol formula Mp (C) Rf value
371 C23H21N3O2 150 0.78
387 C23H21N3O3 145 0.71
401 C24H23N3O3 135 0.65
414 C25H26N4O2 148 0.57
403 C23H21N3O4 142 0.60
430 C25H26N4O3 160 0.67
387 C23H21N3O3 140 0.55
403 C23H21N3O4 135 0.63
403 C23H21N3O4 120 0.69
417 C24H23N3O4 126 0.51
371 C23H21N3O2 206 0.53
387 C23H21N3O3 188 0.63
401 C24H23N3O3 204 0.70
414 C25H26N4O2 195 0.62
403 C23H21N3O4 178 0.58
430 C25H26N4O3 185 0.66
387 C23H21N3O3 180 0.69
403 C23H21N3O4 183 0.54
403 C23H21N3O4 165 0.59
417 C24H23N3O4 172 0.77
Synthesis and reducing power assay of methyl semicarbazone derivatives 125(s, 3H, Ar–CH3), 4.82 (s, 1H, 2-OH), 7.22–7.64 (m, J= 8.3 Hz,
12H, Ar–H), 7.72 (s, 1H, –CH‚CH–), 7.89 (s, 1H,
–CH‚CH–), 8.33 (s, 1H, ArNH, D2O exchangeable), 9.38 (s,
1H, CONH, D2O exchangeable); IR (KBr/cm
1): 3452 (NH),
3485 (–OH), 3300–3243 (CONH), 1668(–CH‚CH–), 1591
(C–N), 1613, 1548 (aromatic), 753, 695 (monosubstituted
benzene); MS, m/z 370; Elemental analysis calculated/found
(%) C (74.37/74.13), H (5.70/5.47), N (11.31/10.98).
2.1.4.8. 1-[1-(2-Hydroxyphenyl)-3-(4-hydroxyphenyl)allylid-
ene]-4-(4-methylphenyl)semicarbazide (15). 1H NMR (d/ppm
in CDCl3): 2.17 (s, 3H, Ar–CH3), 4.91 (s, 1H, 2-OH), 5.3 (s,
1H, 4-OH), 7.3–7.68 (m, J= 8.32 Hz, 11H, Ar–H), 7.79 (s,
1H, –CH‚CH–), 8.1 (s, 1H, –CH‚CH–), 8.42 (s, 1H, ArNH,
D2O exchangeable), 9.85 (s, 1H, CONH, D2O exchangeable);
IR (KBr/cm1): 3449 (NH), 3471 (–OH), 3318–3245 (CONH),
1676 (–CH‚CH–), 1593 (C–N), 1618, 1559 (aromatic), 751,
696 (monosubstituted benzene); MS, m/z 386; Elemental anal-
ysis, cal/fou (%) C (71.30/71.25), H (5.46/5.33), N (10.85/
10.58).
2.1.4.9. 1-[1-(2-Hydroxyphenyl)-3-(4-methoxyphenyl)allylid-
ene]-4-(4-methylphenyl)semicarbazide (16). 1H NMR (d/ppm
in CDCl3): 2.19 (s, 3H, Ar–CH3), 4.74 (s, 1H, 2-OH), 3.83
(s, 3H, 4-OCH3), 7.12–7.85 (m, J= 8.3 Hz, 11H, Ar–H),
7.95 (s, 1H, –CH‚CH–), 8.36 (s, 1H, –CH‚CH–), 8.89
(s, 1H, ArNH, D2O exchangeable), 9.86 (s, 1H, CONH, D2O
exchangeable); IR (KBr/cm1): 3454 (NH), 3479 (–OH),
3310–3243 (CONH), 1672 (–CH‚CH–), 1589 (C–N), 1624,
1556 (aromatic), 753, 687 (monosubstituted benzene); MS,
m/z 400; Elemental analysis cal/fou (%) C (71.80/71.68), H
(5.77/5.67), N (10.47/10.33).
2.1.4.10.1-[1-(2,4-Dihydroxyphenyl)-3-(2-hydroxyphenyl)ally-
lidene]-4-(4-methylphenyl)semicarbazide (18). 1H NMR
(d/ppm in CDCl3): 2.38 (s, 3H, Ar–CH3), 5.22 (s, 1H,
2-OH), 5.37 (s, 1H, 4-OH), 6.43 (s, 1H, 6-OH), 7.22–7.58 (m,
J= 8.32 Hz, 10H, Ar–H) 7.89 (s, 1H, –CH‚CH–), 8.421 (s,
1H, –CH‚CH–), 8.77 (s, 1H, ArNH, D2O exchangeable),
9.86 (s, 1H, CONH, D2O exchangeable); IR (KBr/cm
1):
3456 (NH), 3482 (–OH), 3314–3242 (CONH), 1665
(–CH‚CH–), 1598 (C–N), 1616, 1554 (aromatic), 752, 689
(monosubstituted benzene); MS, m/z 402; Elemental analysis
cal/fou (%) C (68.47/68.44), H (5.25/5.21), N (10.42/10.33).
2.1.4.11. 1-[1-(2-Hydroxyphenyl)-3-(2-hydroxyphenyl)allylid-
ene]-4-(4-methylphenyl)semicarbazide (20). 1H NMR (d/ppm
in CDCl3): 2.25 (s, 3H, Ar–CH3), 5.14 (s, 1H, 2-OH), 5.29 (s,
1H, 2, 4-OH), 7.2–7.77 (m, J= 8.3 Hz, 11H, Ar–H), 7.82 (s,
1H, –CH‚CH–), 8.2 (s, 1H, –CH‚CH–), 8.77 (s, 1H, ArNH,
D2 Oexchangeable), 9.87 (s, 1H, CONH, D2O exchangeable);
IR (KBr/cm1): 3462 (NH), 3488 (–OH), 3300–3240 (CONH),
1666 (–CH‚CH–), 1593 (C–N), 1618, 1554 (aromatic), 753,
694 (monosubstituted benzene); MS, m/z 386; Elemental anal-
ysis cal/fou (%) C (71.30/71.13), H (5.46/5.42), N (10.85/
10.72).
2.1.4.12.1-[1-(2,5-Dihydroxyphenyl)-3-(4-hydroxyphenyl)ally-
lidene]-4-(4-methylphenyl)semicarbazide (22). 1H NMR (d/
ppm in CDCl3): 2.17 (s, 3H, Ar–CH3), 5.45 (s, 1H, 2-OH)
5.22 (s, 1H, 4-OH), 5.61 (s, 3H, 5-OH) 7.22–7.88 (m,
J= 8.6 Hz, 10H, Ar–H), 7.85 (s, 1H, –CH‚CH–), 8.4(s, 1H, –CH‚CH–), 8.82 (s, 1H, ArNH, D2O exchangeable),
9.98 (s, 1H, CONH, D2O exchangeable); IR (KBr/cm
1):
3458 (NH), 3483 (–OH), 3311–3246 (CONH), 1669
(–CH‚CH–), 1595 (C–N), 1617, 1555 (aromatic), 756, 699
(monosubstituted benzene); MS, m/z 402; Elemental analysis
cal/fou (%) C (68.47/68.33), H (5.25/5.13), N (10.42/10.31).
2.2. Reducing power assay
The antioxidant activity of chalconesemicarbazones was
determined by the method of reducing power assay (Oyaizu,
1986). Substances, which have reduction potential, react with
potassium ferricyanide (Fe3+) to form potassium ferrocya-
nide (Fe2+), which then reacts with ferric chloride to form
ferric ferrous complex that has an absorption maximum at
700 nm.
Potassium ferricyanideþ Ferric chloride
!Antioxidant Potassium ferrocyanideþ ferrous chloride
One millilitre of test sample solution (20 lg/ml) was mixed
with phosphate buffer (2.5 ml) and potassium ferricyanide
(2.5 ml). The mixture was incubated at 50 C for 20 min. Ali-
quots of trichloroacetic acid (2.5 ml) were added to the mix-
ture, which was then centrifuged at 3000 rpm for 10 min.
The upper layer of solution (2.5 ml) was mixed with distilled
water (2.5 ml) and a freshly prepared ferric chloride solution
(0.5 ml). The absorbance was measured at 700 nm. Ascorbic
acid (20 lg/ml) was used as standard. A blank was prepared
without adding standard or test compound. Increased absor-
bance of the reaction mixture indicates increase in reducing
power (Khanam et al., 2004).
The percent increase in reducing power was calculated
using the following equation
Increase in reducing power ð%Þ ¼ A testA blank
A blank
 100
where ‘A test’ is absorbance of test solution; ‘A blank’ is absor-
bance of blank.3. Results and discussion
The antioxidant activity of the synthesized chalcone semicar-
bazones was evaluated using reducing power assay. The results
of anti-oxidant screening were depicted in Table 3 and Fig. 5.
Substances, which have reduction potential, react with potas-
sium ferricyanide (Fe3+) to form potassium ferrocyanide
(Fe2+), which then reacts with ferric chloride to form ferric
ferrous complex that has an absorption maximum at 700 nm
(Oyaizu, 1986; Khanam et al., 2004).
As from the tables it could be seen that most of the
compounds showed signiﬁcant antioxidant activity. The high-
est reducing activity observed in compound 18 is probably due
to the presence of hydroxyl group in the acetophenic and
aldehydic moiety of chalcone. The order of activity regarding
substitution on chalconyl group is OH> OCH3 >
(CH3)2–N >H (Venkateswarlu et al., 2006; Singh et al.,
2007; Flynn et al., 1991).
When the observed results were compared, it was observed
that the 4 methyl substituted compounds showed more reduc-
ing power in comparison to the 2 methyl substituted com-
Table 3 Antioxidant activity of chalcone semicarbazones by
reducing power assay.
Compounds Absorbance
(mean ± SD; 700 nm)
% Increase in
reducing power
Control 0.0952 ± 0.0002 –
Standard 0.187 ± 0.0036a 96.43
4 0.1102 ± 0.00026a 15.76
5 0.1429 ± 0.0027a 50.1
6 0.1402 ± 0.00056a 47.27
7 0.1189 ± 0.00036a 24.89
8 0.1803 ± 0.0003a 89.39
9 0.1236 ± 0.0005a 29.83
10 0.1421 ± 0.00026a 49.26
11 0.1763 ± 0.00068a 85.19
12 0.1668 ± 0.00036a 75.21
13 0.1464 ± 0.00046a 53.78
14 0.1179 ± 0.0002a 23.84
15 0.1437 ± 0.00077a 50.94
16 0.1411 ± 0.0001a 48.21
17 0.1208 ± 0.00089a 26.89
18 0.19 ± 0.00199a 99.58
19 0.1281 ± 0.00011a 34.56
20 0.1274 ± 0.0005a 33.82
21 0.1891 ± 0.00044a 98.63
22 0.182 ± 0.00066a 91.18
23 0.1497 ± 0.0006a 57.25
a P< 0.001 compared to control and standard respectively. One
way ANOVA followed by Turkey test.
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Figure 5 Antioxidant activity of chalcone semicarbozones by
reducing power assay.
126 M. Singhal et al.pounds. The substitution with different substituent on the phe-
nyl of the aldehydic and acetophenic group of chalcone moiety
plays an important role in reducing potential of the
compounds.
When the phenyl group of aldehydic and acetophenic moi-
ety of chalcone is substituted with –OH group (compounds 8,
11, 12, 18, 21, 22) the compounds exhibited better activity in
comparison to substitution with the other groups like p-di-
methyl amino groups (compounds 7, 17, 19), methoxy group
(compounds 6, 13, 16, 23) which may be due to more reducingpotential. Hydroxyl substitution on both moieties of chalcone
has more scavenging effect than substitution on any one moi-
ety (Venkateswarlu et al., 2006; Singh et al., 2007; Flynn et al.,
1991). It was found that 6 hydroxyl substitution is more favor-
able than 4 or 5 hydroxyl substitution in the aldehydic moiety
for antioxidant activity.
Methoxy substitution in the aldehydic moiety of chalcone
also favors antioxidant activity (compounds 7–10). It shows
more reducing potential with hydroxyl substitution in the ace-
tophenic moiety than unsubstituted ones (Madhavi et al.,
2010).
Among the synthesized compounds, compounds 18 and 21
showed the better or comparable activity in comparison to the
standard drug while the other compounds showed moderate
reductive potential. In case of bulkier substitution (compounds
7, 9, 17, 19), the substitution increases the activity which may
be due to the high electronegativity. The compounds with no
substitution (compounds 4 and 14) or less substitution showed
very less reducing power in comparison to the substituted com-
pounds due to lesser electronegativity (Venkateswarlu et al.,
2006; Singh et al., 2007; Flynn et al., 1991; Rajasekaran
et al., 2010; Allegra et al., 2003).
In summary, most of the synthesized compounds were po-
tential leads for antioxidant activity. On the bases of ob-
served results, it may be concluded that the substitution
favors the activity, but the lengthening of carbon chain
may also disfavor the activity, may be due to the lesser elec-
tronegativity. The hydroxyl and methoxy substitution in-
creases the activity of the compounds, which may be due to
increased electronegativity.References
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